Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
6.17
+0.05 (0.90%)
Jul 22, 2024, 12:19 PM EDT - Market open
Vanda Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$11.00
Upside
+78.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +78.43% | Jul 11, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +94.65% | Feb 25, 2022 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 14, 2021 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Oct 29, 2020 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 9, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 12, 2020 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2018 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 21, 2018 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Aug 23, 2018 |
| Seaport Global | Seaport Global | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 19, 2018 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 30, 2017 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | May 26, 2017 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 12, 2017 |